Innoforce names Dewan Zeng as the new CEO

03 Aug 2023

Executive Change

Contract developer and manufacturer Innoforce is making changes at the top. The CDMO named Dewan Zeng as its new CEO, effective immediately. Former CEO Yuling Li will stay on as president, focusing specifically on operations, according to a Tuesday press release . Zeng most recently served as the global head of search and evaluation, business development at BeiGene, and before that, as the senior director of clinical services, according to her LinkedIn profile . In the most recent role at BeiGene, she worked on deals between the company and other pharmas. She also held roles at Pfizer, Gilead Sciences and CV Therapeutics before BeiGene.

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

Innoforce Pharmaceuticals Co., Ltd.

BeiGene Ltd.

Pfizer Inc.

[+2]

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.